YOUNG TODD S.
Known title: Chief Financial OfficerCIK: 0001682584
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Elanco (ELAN) Highlighted in Mid-Cap Stock Watchlist. Elanco was included in a recent Yahoo Finance article listing mid-cap stocks to monitor. The company is currently trading near its 52-week low, with an RSI of 38.5 indicating potential oversold conditions. Analysts maintain an average price target of $31.00, which is higher than the current trading level.
Transaction History
| ACHC | ▲ Buy | Grant | 58,799 | $0 | 4/10/2026 | View on chart |
| ACHC | ▲ Buy | Grant | 48,445 | $0 | 10/27/2025 | View on chart |
| ELAN | ▼ Sell | Gift | 2,000 | $0 | 3/4/2025 | View on chart |
| ELAN | ▼ Sell | Gift | 2,000 | $0 | 3/4/2025 | View on chart |
| ELAN | ▼ Sell | Gift | 2,000 | $0 | 3/4/2025 | View on chart |
| ELAN | ▼ Sell | Gift | 2,000 | $0 | 3/4/2025 | View on chart |
| ELAN | ▼ Sell | Gift | 4,000 | $0 | 3/4/2025 | View on chart |
| ELAN | ▼ Sell | Gift | 4,000 | $0 | 3/4/2025 | View on chart |
| ELAN | ▲ Buy | Grant | 64,103 | $0 | 3/3/2025 | View on chart |
| ELAN | ▼ Sell | Tax Withholding | 18,196 | $203K | 3/1/2025 | View on chart |
| ELAN | ▼ Sell | Tax Withholding | 46,045 | $518K | 2/19/2025 | View on chart |
| ELAN | ▲ Buy | Grant | 104,930 | $0 | 2/19/2025 | View on chart |
| ELAN | ▼ Sell | Gift | 1,500 | $0 | 3/5/2024 | View on chart |
| ELAN | ▼ Sell | Gift | 1,500 | $0 | 3/5/2024 | View on chart |
| ELAN | ▼ Sell | Gift | 1,500 | $0 | 3/5/2024 | View on chart |
| ELAN | ▼ Sell | Gift | 1,500 | $0 | 3/5/2024 | View on chart |
| ELAN | ▼ Sell | Gift | 37,999 | $0 | 3/5/2024 | View on chart |
| ELAN | ▼ Sell | Gift | 37,999 | $0 | 3/5/2024 | View on chart |
| ELAN | ▼ Sell | Tax Withholding | 14,000 | $224K | 3/1/2024 | View on chart |
| ELAN | ▲ Buy | Grant | 43,903 | $0 | 3/1/2024 | View on chart |
| ELAN | ▲ Buy | Grant | 36,440 | $0 | 2/27/2024 | View on chart |
| ELAN | ▼ Sell | Tax Withholding | 16,084 | $265K | 2/27/2024 | View on chart |
| ELAN | ▼ Sell | Gift | 2,000 | $0 | 3/15/2023 | View on chart |
| ELAN | ▼ Sell | Gift | 2,000 | $0 | 3/15/2023 | View on chart |
| ELAN | ▼ Sell | Gift | 2,000 | $0 | 3/15/2023 | View on chart |
| ELAN | ▼ Sell | Gift | 2,000 | $0 | 3/15/2023 | View on chart |
| ELAN | ▼ Sell | Gift | 118,309 | $0 | 3/14/2023 | View on chart |
| ELAN | ▼ Sell | Gift | 118,309 | $0 | 3/14/2023 | View on chart |
| ELAN | ▲ Buy | Grant | 66,655 | $0 | 3/2/2023 | View on chart |
| ELAN | ▼ Sell | Tax Withholding | 2,200 | $24K | 3/2/2023 | View on chart |
| ELAN | ▼ Sell | Tax Withholding | 29,049 | $320K | 3/2/2023 | View on chart |
| ELAN | ▼ Sell | Tax Withholding | 5,600 | $63K | 3/1/2023 | View on chart |
| ELAN | ▲ Buy | Grant | 58,060 | $0 | 3/1/2023 | View on chart |
| ELAN | ▼ Sell | Other | 1,562 | — | 2/1/2023 | View on chart |
| ELAN | ▼ Sell | Tax Withholding | 2,135 | $62K | 3/2/2022 | View on chart |
| ELAN | ▼ Sell | Tax Withholding | 3,747 | $108K | 3/1/2022 | View on chart |
| ELAN | ▲ Buy | Grant | 21,683 | $0 | 3/1/2022 | View on chart |
| ELAN | ▼ Sell | Tax Withholding | 22,557 | $586K | 2/22/2022 | View on chart |
| ELAN | ▲ Buy | Grant | 55,205 | $0 | 2/22/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Acadia Healthcare Sets Q3 2026 Earnings Date
Acadia Healthcare announced the date for its third-quarter 2026 earnings release. This update provides a timeline for the next major financial report from the company. The stock is currently trading within its 52-week range of $11.43 to $35.83, with an average analyst target price of $33.79.
Acadia Healthcare Sets Q3 2026 Earnings Date. Acadia Healthcare announced the date for its third-quarter 2026 earnings release. This update provides a timeline for the next major financial report from the company. The stock is currently trading within its 52-week range of $11.43 to $35.83, with an average analyst target price of $33.79.